NCT03539302 - INhalation of Flecainide to Convert Recent Onset SympTomatic Atrial Fibrillation to siNus rhyThm (INSTANT) | Biotech Hunter

Enrollment

176

Participants

Timeline

Start Date

May 29, 2018

Primary Completion Date

January 17, 2022

Study Completion Date

January 17, 2022

Conditions

Paroxysmal Atrial Fibrillation (PAF)

Interventions

DRUG

Flecainide Acetate

Oral inhalation form using a nebulizer

Trial Locations (9)

Imelda, Bonheiden

OLVG, Amsterdam

Deventer Ziekenhuis, Deventer

Admiraal De Ruyter Ziekenhuis, Goes

UMCG, Groningen

Spaarne Gasthuis, Haarlem

Maastricht University Medical Center, Maastricht

Gelre Ziekenhuizen, Zutphen

Isala Klinieken, Zwolle